» Articles » PMID: 36506650

Inflammation and Depression Symptoms Are Most Strongly Associated for Black Adults

Overview
Date 2022 Dec 12
PMID 36506650
Authors
Affiliations
Soon will be listed here.
Abstract

Although race/ethnicity is associated with substantial differences in risk for depression and other diseases of aging in the United States, the processes underlying these health disparities remain poorly understood. We addressed this issue by examining how levels of a robust marker of inflammatory activity, C-reactive protein (CRP), and depression symptoms varied across racial/ethnic groups. Additionally, we tested whether the inflammation-depression association differed across groups. Data were drawn from the Chicago Community Adult Health Survey, an epidemiological survey examining biopsychosocial factors affecting health and well-being. Participants were 3105 Chicago community adults, of which 610 provided blood samples and were included in analyses. C-reactive protein was assayed from blood samples, and depression symptoms were assessed using the 11-item Center for Epidemiologic Studies-Depression scale. Race/ethnicity was self-reported and consisted of Black, Hispanic, White, and other racial/ethnic groups. Results revealed that these racial/ethnic groups differed in terms of both their CRP and depression levels. Specifically, Black Americans exhibited higher levels of CRP as compared to White and other race/ethnicity Americans. Moreover, Black Americans exhibited more depression symptoms than Hispanic Americans. Finally, we found that inflammatory levels were strongly related to depression symptoms but only for Black Americans, with CRP alone accounting for 8% of the variance in depression symptoms in this subgroup. These data thus point to a biological process that may help to explain disparities in mental health outcomes across race/ethnicity in the United States. At the same time, additional research is needed to understand the social and structural factors driving these effects.

Citing Articles

Multi-omics approaches in psychoneuroimmunology and health research: Conceptual considerations and methodological recommendations.

Mengelkoch S, Schussler-Fiorenza Rose S, Lautman Z, Alley J, Roos L, Ehlert B Brain Behav Immun. 2023; 114:475-487.

PMID: 37543247 PMC: 11195542. DOI: 10.1016/j.bbi.2023.07.022.


Connecting the dots from east to west.

Kelley K, Felger J, Bekhbat M Brain Behav Immun Health. 2022; 26:100569.

PMID: 36561467 PMC: 9763371. DOI: 10.1016/j.bbih.2022.100569.

References
1.
Bey G, Jesdale B, Ulbricht C, Mick E, Person S . Allostatic Load Biomarker Associations with Depressive Symptoms Vary among US Black and White Women and Men. Healthcare (Basel). 2018; 6(3). PMC: 6163528. DOI: 10.3390/healthcare6030105. View

2.
Morris A, Zhao L, Ahmed Y, Stoyanova N, De Staercke C, Hooper W . Association between depression and inflammation--differences by race and sex: the META-Health study. Psychosom Med. 2011; 73(6):462-8. PMC: 3951048. DOI: 10.1097/PSY.0b013e318222379c. View

3.
Nazmi A, Victora C . Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health. 2007; 7:212. PMC: 2018719. DOI: 10.1186/1471-2458-7-212. View

4.
Carleton R, Thibodeau M, Teale M, Welch P, Abrams M, Robinson T . The center for epidemiologic studies depression scale: a review with a theoretical and empirical examination of item content and factor structure. PLoS One. 2013; 8(3):e58067. PMC: 3585724. DOI: 10.1371/journal.pone.0058067. View

5.
Straka K, Tran M, Millwood S, Swanson J, Kuhlman K . Aging as a Context for the Role of Inflammation in Depressive Symptoms. Front Psychiatry. 2021; 11:605347. PMC: 7848015. DOI: 10.3389/fpsyt.2020.605347. View